Pityriasis rosea in pregnancy: A case series and literature review

J Dtsch Dermatol Ges. 2022 Jul;20(7):953-959. doi: 10.1111/ddg.14763. Epub 2022 May 26.

Abstract

Background and objective: Pityriasis rosea (PR), a common skin disease in young adults, may adversely affects the course of pregnancy and the unborn child.

Patients and methods: Data from forty-six pregnant women with PR seen in the dermatological university clinic between 2003 and 2018 were analyzed and compared with patient data (n = 53) from previously published studies to determine the incidence and risk factors for an unfavorable pregnancy outcome after PR infection.

Results: Unfavorable pregnancy outcomes (defined as miscarriage, preterm delivery before week 37 of gestation, or birth weight < 2,500 g) were significantly less frequent in our study population than in a pooled cohort obtained from previously published studies (10.9 % vs. 39.6 %; P = 0.0012). Analysis of pooled data from our study and from previous studies revealed that the week of pregnancy at onset of PR was inversely associated with an unfavorable outcome (odds ratio [OR] = 0.937; 95 % CI 0.883 to 0.993). In addition, duration of PR (OR = 1.432; 95 % CI 1.129 to 1.827), additional extracutaneous symptoms (OR = 4.112; 95 % CI 1.580 to 10.23), and widespread rash distribution (OR 5.203, 95 % CI 1.702 to 14.89) were directly associated with unfavorable outcome.

Conclusion: In most cases, PR does not influence pregnancy or birth outcomes.

Publication types

  • Review

MeSH terms

  • Cohort Studies
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Pityriasis Rosea* / diagnosis
  • Pityriasis Rosea* / epidemiology
  • Pregnancy
  • Pregnancy Complications* / diagnosis
  • Pregnancy Complications* / epidemiology
  • Risk Factors
  • Young Adult